AINDEX
Markets

Gilead Sciences, Inc. (GILD)

GILDNASDAQ-GSBiotechnology: Biological Products (No Diagnostic Substances)

$167.58

-0.5000 (-0.30%) today

Closed, Nov 16, 4:00 PM ET

-0.30% 1D
Market cap
$208.48bn
P/E
–
EPS, last 4 quarters
$-0.3100
Dividend yield
1.95%
Day range
–
52-week range
$116.88 to $176.58
Average volume
–
Previous close
$168.08

Analysts

22 covering

Buy17 buy, 5 hold, 0 sell

Targets a year out average $174.48, +4.1% from here

$131.00now $167.58$200.00

Earnings

next estimate $1.14

Next report

Dec 2025

+1.6%

Mar 2026

+7.4%

Jun 2026

+4.5%

Sep 2026

+17.5%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$7.92bn$6.96bn$7.80bn$8.30bn
Gross profit$6.30bn$5.51bn$6.22bn$6.73bn
Operating income$1.98bn$2.59bn-$10.39bn$3.46bn
Net income$2.18bn$2.02bn-$10.50bn$2.43bn

Last four quarters: revenue $30.99bn, margin -12.5%, free cash flow $13.78bn

News

8 latest

The company

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. In 2025, Gilead announced a $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness, while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Exchange
NASDAQ-GS
Region
North America
Website
gilead.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Gilead Sciences, Inc. (GILD) price, chart and news · AINDEX